BONUS ZERTIFIKAT - SANOFI Share Price

Certificat

DE000VM3PZY7

Market Closed - Deutsche Boerse AG 19:03:22 31/05/2024 BST
126.5 EUR +0.33% Intraday chart for BONUS ZERTIFIKAT - SANOFI
1 month+1.76%
3 months+7.54%
Date Price Change
31/05/24 126.5 +0.33%
30/05/24 126.1 +0.40%
29/05/24 125.6 +0.20%
28/05/24 125.3 -0.75%
27/05/24 126.3 +0.33%

Delayed Quote Deutsche Boerse AG

Last update May 31, 2024 at 07:03 pm

More quotes

Static data

Product typeBonus- and Part-Guarantee-Certificates
Buy / SellCALL
Underlying SANOFI
IssuerLogo Issuer Vontobel Vontobel
WKN VM3PZY
ISINDE000VM3PZY7
Date issued 12/10/2023
Strike 130
Maturity 20/09/2024 (111 Days)
Parity 1 : 1
Emission price 119.7
Emission volume N/A
Settlement both
Currency EUR

Technical Indicators

Highest since issue 127.1
Lowest since issue 97.97
Spread 0.97
Spread %0.76%

Company Profile

Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (70.6%): prescription drugs in the areas of specialty medicine (59.3% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (40.7%; mainly for the treatment of diabetes and cardiovascular diseases); - human vaccines (17.4%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas; - consumer health products (12%). At the end of 2023, the group had 54 production sites throughout the world. Net sales are distributed geographically as follows: France (5.5%), Europe (18.6%), the United States (43%), North America (1.6%) and other (31.3%).
Sector
-
More about the company

Ratings for Sanofi

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Sanofi

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
89.76 EUR
Average target price
108.2 EUR
Spread / Average Target
+20.53%
Consensus